Teleflex Incorporated (TFX) Director Sells $631,425.00 in Stock

Teleflex Incorporated (NYSE:TFX) Director George Babich, Jr. sold 2,500 shares of Teleflex stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $252.57, for a total value of $631,425.00. Following the transaction, the director now directly owns 10,259 shares in the company, valued at approximately $2,591,115.63. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Shares of Teleflex Incorporated (NYSE:TFX) traded down $0.25 during trading on Tuesday, reaching $254.95. The company had a trading volume of 170,277 shares, compared to its average volume of 286,536. The company has a market capitalization of $11,386.20, a price-to-earnings ratio of 31.24, a P/E/G ratio of 1.86 and a beta of 1.15. Teleflex Incorporated has a 1-year low of $175.00 and a 1-year high of $288.78. The company has a quick ratio of 3.70, a current ratio of 4.72 and a debt-to-equity ratio of 0.88.

Several brokerages recently issued reports on TFX. Leerink Swann reaffirmed a “buy” rating and set a $321.00 target price (up previously from $307.00) on shares of Teleflex in a research report on Tuesday, January 30th. Stephens reaffirmed a “buy” rating and set a $300.00 target price on shares of Teleflex in a research report on Thursday, January 18th. ValuEngine cut Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Morgan Stanley lifted their target price on Teleflex from $274.00 to $290.00 and gave the company an “equal weight” rating in a research report on Friday, November 3rd. Finally, Jefferies Group lifted their price target on Teleflex from $270.00 to $295.00 and gave the stock a “buy” rating in a report on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $283.89.

A number of institutional investors have recently modified their holdings of TFX. American Century Companies Inc. lifted its holdings in Teleflex by 41.6% during the third quarter. American Century Companies Inc. now owns 1,187,909 shares of the medical technology company’s stock worth $287,438,000 after acquiring an additional 348,829 shares during the period. Renaissance Technologies LLC lifted its holdings in Teleflex by 511.6% during the fourth quarter. Renaissance Technologies LLC now owns 195,700 shares of the medical technology company’s stock worth $48,694,000 after acquiring an additional 163,700 shares during the period. BlackRock Inc. lifted its holdings in Teleflex by 3.4% during the fourth quarter. BlackRock Inc. now owns 4,709,341 shares of the medical technology company’s stock worth $1,171,779,000 after acquiring an additional 156,527 shares during the period. Mackay Shields LLC bought a new stake in Teleflex during the third quarter worth $29,644,000. Finally, First Trust Advisors LP lifted its holdings in Teleflex by 126.7% during the fourth quarter. First Trust Advisors LP now owns 119,580 shares of the medical technology company’s stock worth $29,754,000 after acquiring an additional 66,822 shares during the period. Institutional investors and hedge funds own 89.22% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Teleflex Incorporated (TFX) Director Sells $631,425.00 in Stock” was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://www.americanbankingnews.com/2018/02/13/teleflex-incorporated-tfx-director-sells-631425-00-in-stock.html.

Teleflex Company Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Insider Buying and Selling by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply